Carcinogen-induced histone alteration in normal human mammary epithelial cells

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2184-2192

  Bradley, Chastity ^a   van der Meer, Riet ^a   Roodi, Nady ^a   Yan, Heping ^b   Chandrasekharan, Mahesh B ^b   Sun, Zu Wen ^a   Mernaugh, Ray L ^b   Parl, Fritz F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 BIPHENYLAMINE; BENZO[A]PYRENE; CARCINOGEN; ENZYME; HISTONE H3; LYSINE; LYSINE SPECIFIC DEMETHYLASE 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL NUCLEUS; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; ENZYME INDUCTION; ENZYME LOCALIZATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN TARGETING;

AMINOBIPHENYL COMPOUNDS; BENZO(A)PYRENE; BIOTINYLATION; BREAST; CARCINOGENS; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HISTONES; HUMANS; IMIDAZOLES; IMMUNOGLOBULIN VARIABLE REGION; PEPTIDE LIBRARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRACHLORODIBENZODIOXIN;

EID: 35148819644     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm100     Document Type: Article

References (59)

1. Snyderwine,E.G. et al. (1998) Proliferation, development and DNA adduct levels in the mammary gland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a high fat diet. Carcinogenesis, 19, 1209-1215.
2. Dingley,K.H. et al. (1999) DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol. Biomarkers Prev., 8, 507-512.
3. Fang,M. et al. (2004) Urinary N2-(2′-deoxyguanosin-8-yl PhIP as a biomarker for PhIP exposure. Carcinogenesis, 25, 1053-1062.
4. Fields,W.R. et al. (2004) Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo[a]pyrene-7,8-9,10 diol epoxide. Mol. Carcinog., 40, 79-89.
5. Ellsworth,D.L. et al. (2004) Genomic instability in histologically normal breast tissues: Implications for carcinogenesis. Lancet Oncol. 5, 753-758.
6. Kendall,S.D. et al. (2005) A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res., 65, 9824-9828.
7. Emberley,E.D. et al. (2003) Psoriasin interacts with Jab1. and influences breast cancer progression. Cancer Res., 63, 1954-1961.
8. Gauthier,M.L. et al. (2005) p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res., 65, 1792-1799.
9. Nagaraja,G.M. et al. (2006) Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene, 25, 2328-2338.
10. Yao,J. et al. (2006) Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res., 66, 4065-4078.
11. Stausbol-Gron,B. et al. (2001) De novo identification of cell-type specific antibody-antigen pairs by phage display subtraction. Isolation of a human single chain antibody fragment against human keratin 14. Eur. J. Biochem., 268, 3099-3107.
12. Ito,N. et al. (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-Phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
13. Snyderwine,E.G. (1994) Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer, 74, 1070-1077.
14. Sutter,T.R. et al. (1991) Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science, 254, 415-418.
15. Perera,F.P. et al. (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev., 4, 233-238.
16. Li,D. et al. (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res. 56, 287-293.
17. Phillips,D.H. (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat. Res., 443, 139-147.
18. Gould,M.N. et al. (1982) Human breast cell-mediated mutagenesis of mammalian cells by polycyclic aromatic hydrocarbons. Cancer Res., 42, 4619-4624.
19. Debiec-Rychter,M. et al. (1998) DNA adduct formation in human and rat mammary epithelium by N-hydroxy derivatives of 2-aminofluorene and 4-aminobiphenyl. Teratog., Carcinog. Mutagen., 18, 35-39.
20. Jeffy,B.D. et al. (2002) Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors. Environ. Mol. Mutagen., 39, 235-244.
21. Zhang,Y. et al. (2004) Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides. Biochemistry, 43, 12575-12584.
22. Pope,T. et al. (1996) Construction and use of antibody gene repertories. In McCafferty,J.,Chiswell,D. and Hoogenboom,H. (eds.) Antibody Engineering: A practical approach. IRL, pp. 1-40.
23. Martinez-Torrecuadrada,J. et al. (2005) Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation. Clin. Cancer Res., 11, 6280-6290.
24. Friedman,D.B. et al. (2004) Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics, 4, 793-811.
25. Gallagher,S. et al. (2004) Immunoblotting and immunodection. In Ausubel, F.M.,Brent,R.,Kingston,R.E.,Moore,D.D.,Seidman,J.G.,Smith,J.A.,StruhlK (eds.) Current protocols in Molecular Biology. John Wiley & Sons, Inc., pp. 10.8.1-10,8.24.
26. Hendzel,M.J. et al. (1997) Fixation-dependent organization of core histones following DNA fluorescent in situ hybridization. Chromosoma 106, 114-123.
27. Choi,H.S. et al. (2005) Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-like mitogen-activated protein triple kinase alpha. J. Biol. Chem., 280, 13545-13553.
28. Shi,Y. et al. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119, 941-953.
29. Metzger,E. et al. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439.
30. Sheffield,L.G. (1998) Epidermal growth factor as an autocrine modulator of stress response in mammary epithelial cells. J. Endocrinol., 159, 111-116.
31. Mori,K. et al. (2004) Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res., 64 7464-7472.
32. Gorlewska-Roberts,K. et al. (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen., 39, 184-192.
33. Peletskaya,E.N. et al. (1997) Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. J. Mol. Biol., 270, 374-384.
34. Smith,G.P. et al. (1997) Phage display. Chem. Rev., 97 391-410.
35. Koivunen,E. et al. (1999) Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol., 17, 768-774.
36. Willats,W.G. (2002) Phage display: Practicalities and prospects. Plant Mol. Biol., 50, 837-854.
37. Pasqualini,R. et al. (1996) Organ targeting in vivo using phage display peptide libraries. Nature, 380, 364-366.
38. Arap,W. et al. (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377-380.
39. Newton,J.R. et al. (2006) In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 8, 772-780.
40. Zou,J. et al. (2004) Biodistribution of filamentous phage peptide libraries in mice. Mol. Biol. Rep., 31, 121-129.
41. Russo,G. et al. (2003) Advantages and limitations of microarray technology in human cancer. Oncogene, 22, 6497-6507.
42. Bode,A.M. et al. (2005) Inducible covalent posttranslational modification of histone H3. Sci. STKE, 2005, re4.
43. Jenuwein,T. et al. (2001) Translating the histone code. Science 293, 1074-1080.
44. Kubicek,S. et al. (2004) A crack in histone lysine methylation. Cell, 119, 903-906.
45. Cheung,P. et al. (2005) Epigenetic regulation by histone methylation and histone variants. Mol. Endocrinol., 19, 563-573.
46. Trojer,P. et al. (2006) Histone lysine demethylases and their impact on epigenetics. Cell, 125, 213-217.
47. Byvoet,P. et al. (1972) The distribution and turnover of labeled methyl groups in histone fractions of cultured mammalian cells. Arch. Biochem. Biophys., 148, 558-567.
48. Bannister,A.J. et al. (2005) Reversing histone methylation. Nature, 436, 1103-1106.
49. Forneris,F. et al. (2005) Human histone demethylase LSD1 reads the histone code. J. Biol. Chem., 280, 41360-41365.
50. Segal,E. et al. (2006) A genomic code for nucleosome positioning. Nature, 442, 772-778.
51. Hamamoto,R. et al. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol., 6, 731-740.
52. Marks,P. et al. (2001) Histone deacetylases and cancer: Causes and therapies. Nat. Rev. Cancer, 1, 194-202.
53. Secrist,J.P. et al. (2003) HDAC inhibitors for the treatment of cancer. Curr. Opin. Investig. Drugs, 4, 142-1427.
54. Richon,V.M. et al. (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl Acad Sci. USA, 95, 3003-3007.
55. Scott,G.K. et al. (2002) Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Mol. Cancer Ther., 1, 385-392.
56. Kelly,W.K. et al. (2003) Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously. Clin. Cancer Res., 9, 3578-3588.
57. Marks,P.A. et al. (2003) Histone deacetylases. Curr. Opin. Pharmacol., 3, 344-351.
58. Lee,M.G. et al. (2006) Functional interplay between histone demethylase and deacetylase enzymes. Mol. Cell. Biol., 26, 6395-6402.
59. Seligson,D.B. (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.